Sorrento Presents Preliminary Results of STI-2020 Against COVID-19
Shots: The acquisition includes NextWave with its two novels ADHD (Attention Deficit Hyperactivity Disorder) treatments, co-developed by NextWave and Tris using Tris’ novel, LiquiXR platform Tris has expanded its ADHD product portfolio with the acquisition of Quillivant XR and QuilliChew ER, which already has Dyanavel XR for ADHD treatment. In 2012, Pfizer acquired NextWave for […]Read More
